SUBSCRIBE
SUBSCRIBE
News   Deals

IMS Health to be Sold for $5.2 Billion, Employs 1,000 in Plymouth Meeting

November 6, 2009 | 
1 min read

Bookmark and Share

Philadelphia Business Journal -- IMS Health entered into a definitive agreement Thursday to be acquired for $5.2 billion by investment funds managed by TPG Capital and the CPP Investment Board of Toronto.

Mergers & acquisitions
MORE ON THIS TOPIC
Business
Trump Takes Over, Wegovy Still Trails Zepbound and BioSpace Recaps JPM
January 22, 2025
 · 
1 min read
 · 
Heather McKenzie
Women holding hands over a red circle on a geometric shapes background
Business
Under Pressure to Deal, Biogen Executives Deflect Urgency at JPM25
January 15, 2025
 · 
3 min read
 · 
Annalee Armstrong
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: Aerial view of the San Francisco skyline
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
January 15, 2025
 · 
4 min read
 · 
Tristan Manalac